Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study.

Carl H GöbelAxel HeinzeSarah KarstedtMascha MorscheckLilian TashiroAnna CirkelQutyaba HamidRabih HalwaniMohamad-Hani TemsahMalte ZiemannSiegfried GörgThomas MünteHartmut Göbel

Published in: Pain and therapy (2021)

Headaches attributed to COVID-19 vaccination with the ChAdOx1 nCoV-19 (AZD1222) vaccine demonstrate an extensive and characteristic complex of symptoms. The findings have several important clinical implications for the differentiation of post-vaccinal headache and other primary as well as secondary headaches.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
cross sectional
depressive symptoms
sleep quality